171 results
Page 5 of 9
6-K
EX-99.1
8q2f 63ipp9
24 Jun 19
Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition
9:01am
6-K
EX-99.1
zkfa 7auobfuw
19 Jun 19
Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call
8:00am
6-K
EX-99.1
ykumf5jx
4 Jun 19
Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia
9:15am
6-K
EX-99.1
6lflmz2
21 May 19
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
7:31am
6-K
EX-99.1
r6q6utrqqt6wyrz j8vg
15 May 19
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel
7:56am
6-K
EX-99.1
eopokfas
24 Apr 19
Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City
8:35am
6-K
EX-99.1
riwyd6
15 Apr 19
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
9:15am
6-K
EX-99.1
37n9bd kn56q5l
26 Mar 19
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd
8:30am
6-K
EX-99.1
8iwtas8
13 Mar 19
Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th
8:30am
6-K
EX-99.1
9fqjzvna93zbk0p
21 Feb 19
Current report (foreign)
9:15am
424B5
7y0 n4kf8
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
EX-99.1
uxl3bc3
14 Feb 19
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019
8:05am
6-K
EX-99.2
k2d evv25kj69a
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.1
tk7npbuwp
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.1
i9ogaok
9 Jan 19
Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office
8:05am
6-K
EX-99.1
6a8xpe3m2y
31 Dec 18
Current report (foreign)
8:00am
6-K
EX-99.1
b84lblmwgg kamfq
20 Dec 18
Acasti Pharma Achieves Planned Enrollment Targets for TRILOGY Phase 3 Trials of CaPre® in Patients with Severe Hypertriglyceridemia
8:01am
6-K
EX-99.1
tp1jc1m
14 Nov 18
Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019
8:05am
6-K
EX-99.2
wunv6tskod kgk1h6w3
14 Nov 18
Current report (foreign)
7:00am
6-K
EX-99.1
gx2fxuc 8p23
14 Nov 18
Current report (foreign)
7:00am